Bellevue Group’s Voyager Therapeutics VYGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-31,800	Closed	-$150K	–	224
2021 Q1	$150K	Sell	31,800 -2,680,283	-99%	-$18.3M	﹤0.01%	216
2020 Q4	$19.4M	Hold	2,712,083	–	–	0.22%	102
2020 Q3	$28.9M	Hold	2,712,083	–	–	0.4%	69
2020 Q2	$34.2M	Sell	2,712,083 -12,000	-0.4%	-$140K	0.48%	53
2020 Q1	$24.9M	Buy	2,724,083 +19,800	+0.7%	+$227K	0.48%	54
2019 Q4	$37.7M	Sell	2,704,283 -400	-0%	-$5.81K	0.6%	44
2019 Q3	$46.5M	Buy	2,704,683 +24,400	+0.9%	+$512K	0.87%	35
2019 Q2	$73M	Buy	+2,680,283	New	+$61.3M	1.25%	24
2019 Q1	–	Sell	-27,900	Closed	-$262K	–	152
2018 Q4	$262K	Sell	27,900 -15,522	-36%	-$199K	0.02%	136
2018 Q3	$822K	Buy	43,422 +26,500	+157%	+$508K	0.05%	129
2018 Q2	$331K	Buy	+16,922	New	+$334K	0.03%	137